title: Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?
authors.affiliation: Department of Cardiology, Charité Universitätsmedizin, Hindenburgdamm 30, 12203 Berlin, Germany.
authors.forename: Marco
authors.initials: M
authors.lastname: Witkowski
authors.affiliation: Department of Cardiology, Charité Universitätsmedizin, Hindenburgdamm 30, 12203 Berlin, Germany.
authors.forename: Daniel
authors.initials: D
authors.lastname: Steffens
authors.affiliation: Department of Cardiology, Charité Universitätsmedizin, Hindenburgdamm 30, 12203 Berlin, Germany.
authors.forename: Adel
authors.initials: A
authors.lastname: Hassanein
authors.affiliation: Medical Microbiology and Hygiene, Obere Zahlbacher str. 67, 55131 Mainz, Germany.
authors.forename: Mario
authors.initials: M
authors.lastname: Witkowski
authors.affiliation: Department of Cardiology, Charité Universitätsmedizin, Hindenburgdamm 30, 12203 Berlin, Germany.
authors.forename: Nicolle
authors.initials: N
authors.lastname: Kränkel
authors.affiliation: Department of Cardiology, Charité Universitätsmedizin, Hindenburgdamm 30, 12203 Berlin, Germany.
authors.forename: Andrea
authors.initials: A
authors.lastname: Doerner
authors.affiliation: Department of Cardiology, Charité Universitätsmedizin, Hindenburgdamm 30, 12203 Berlin, Germany.
authors.forename: Julian
authors.initials: J
authors.lastname: Friebel
authors.affiliation: Department of Cardiology, Charité Universitätsmedizin, Hindenburgdamm 30, 12203 Berlin, Germany.
authors.forename: Ulf
authors.initials: U
authors.lastname: Landmesser
authors.affiliation: Department of Cardiology, Charité Universitätsmedizin, Hindenburgdamm 30, 12203 Berlin, Germany. Electronic address: ursula.rauch@charite.de.
authors.forename: Ursula
authors.initials: U
authors.lastname: Rauch
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D000069604:Dabigatran / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000378:metabolism; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D013917:Thrombin / Q000378:metabolism*; D013927:Thrombosis / Q000188:drug therapy* / Q000378:metabolism
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D010446:Peptide Fragments; D010975:Platelet Aggregation Inhibitors; C086309:thrombin receptor peptide SFLLRNP; D013917:Thrombin; D000069604:Dabigatran